Tag: preclinical
-
Post-Stroke Injection Protects Brain in Preclinical Study
Overview: A New Approach to Stroke Care When a stroke hits, restoring blood flow is the first priority to save lives. Yet the very act of reperfusing the brain can trigger a secondary wave of damage, known as reperfusion injury, that worsens inflammation and neuronal death. In a recent preclinical study, researchers tested a post-stroke…
-
Post-Stroke Injection Protects the Brain in Preclinical Study
New Findings Suggest a Post-Stroke Injection Could Mitigate Brain Damage In the race against stroke, every minute counts. While restoring blood flow to the brain is essential to save lives, the sudden return of blood can paradoxically cause additional harm. Emerging preclinical research now suggests that a targeted injection administered after a stroke may protect…
-
AI-Optogenetics Platform for Early Parkinson’s Diagnosis and Therapy
A Groundbreaking Platform: AI Meets Optogenetics KAIST researchers have unveiled a pioneering preclinical platform that fuses artificial intelligence (AI) with optogenetics to advance both the diagnosis and treatment of Parkinson’s disease. The announcement, made by KAIST president Kwang Hyung Lee on September 22, highlights a collaboration spanning the university’s Biological Sciences, Brain and Cognitive Sciences,…
-
AI-Optogenetics Platform Bridges Early Parkinson’s Diagnosis and Therapy
A New AI-Optogenetics Platform for Parkinson’s A breakthrough in Parkinson’s disease research emerged from a Korean collaboration that fuses artificial intelligence with optogenetics. Announced by KAIST on September 22, the study brings together the expertise of Professor Won Do Heo (Department of Biological Sciences), Professor Daesoo Kim (Department of Brain and Cognitive Sciences), and Director…
-
AI-Optogenetics Platform for Parkinson’s Diagnosis and Therapy
Breakthrough: AI meets optogenetics for Parkinson’s diagnosis and treatment A pioneering preclinical platform from a Korean team at KAIST merges artificial intelligence with optogenetics to transform how Parkinson’s disease (PD) is diagnosed and therapeutically evaluated. The researchers, guided by Prof. Won Do Heo, Prof. Daesoo Kim, and Director Chang-Jun Lee, spotlight a path that could…